As part of the commercialization process, a startup company may be the most appropriate vehicle for bringing a new technology to market. Temple University is uniquely positioned to facilitate the creation of new startup companies through its Office of Strategic Initiatives and Corporate Partners (OSI). OTT and OSI work in close partnership to bring new companies to a stage appropriate for licensing technology from Temple.
Creative Footwear Technology, a bio-design shoe manufacturing company is a partnership between Drs. James McGuire and Kendrick Whitney, School of Podiatric Medicine along with Richard Posoff, entrepreneur and Temple University to commercialize patent pending orthotic shoe and insole assemblies. The shoe design is crafted with comfort in mind and will be initially targeted to those suffering from diabetic foot ulcers. See http://www.creativefootweartechnology.com for more information.
Formed to commercialize a wide variety of anticancer and anti-inflammatory compounds, including a new class of COX-2 inhibitors, developed by Dr. E. Premkumar Reddy and his collaborators (Biochemistry Department and Fels Institute, School of Medicine). [Onconova Therapeutics Inc. Website]
Formed to commercialize the discovery by Dr. Robert Suhadolnik and collaborators (Biochemistry Department and Fels Institute, School of Medicine) of an abnormal low molecular weight RNase L protein in chronic fatigue syndrome (CFS) patients. Prior to this discovery there was no diagnostic test for CFS, and physicians had to rely solely on a combination of clinical symptoms, each of which can also be due to other disease conditions. [R.E.D. Laboratories NV Website]
Phone: (215) 204-5732
Fax: (215) 204-7486
